629 related articles for article (PubMed ID: 28281738)
41. Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial.
Liu J; Xie Y; He F; Gao Z; Hao Y; Zu X; Chang L; Li Y
Biomed Res Int; 2016; 2016():5985327. PubMed ID: 26949703
[TBL] [Abstract][Full Text] [Related]
42. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
43. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies.
Azzalini L; Spagnoli V; Ly HQ
Can J Cardiol; 2016 Feb; 32(2):247-55. PubMed ID: 26277092
[TBL] [Abstract][Full Text] [Related]
44. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
45. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O
Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264
[TBL] [Abstract][Full Text] [Related]
46. Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients.
Giacoppo D; Gargiulo G; Buccheri S; Aruta P; Byrne RA; Cassese S; Dangas G; Kastrati A; Mehran R; Tamburino C; Capodanno D
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487354
[TBL] [Abstract][Full Text] [Related]
47. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
Amini M; Salarifar M; Amirbaigloo A; Masoudkabir F; Esfahani F
Trials; 2009 Jun; 10():45. PubMed ID: 19563648
[TBL] [Abstract][Full Text] [Related]
48. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.
Maioli M; Toso A; Leoncini M; Micheletti C; Bellandi F
Circ Cardiovasc Interv; 2011 Oct; 4(5):456-62. PubMed ID: 21972403
[TBL] [Abstract][Full Text] [Related]
49. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
[TBL] [Abstract][Full Text] [Related]
50. Prevention of contrast-induced nephropathy with ascorbic acid.
Zhou L; Chen H
Intern Med; 2012; 51(6):531-5. PubMed ID: 22449658
[TBL] [Abstract][Full Text] [Related]
51. Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial.
Gomes VO; Lasevitch R; Lima VC; Brito FS; Perez-Alva JC; Moulin B; Arruda A; Oliveira D; Caramori P
Arq Bras Cardiol; 2012 Dec; 99(6):1129-34. PubMed ID: 23184077
[TBL] [Abstract][Full Text] [Related]
52. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
53. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.
Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
Int J Cardiovasc Imaging; 2017 May; 33(5):595-604. PubMed ID: 27995343
[TBL] [Abstract][Full Text] [Related]
54. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
55. Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Rezaei Y; Khademvatani K; Rahimi B; Khoshfetrat M; Arjmand N; Seyyed-Mohammadzad MH
J Am Heart Assoc; 2016 Mar; 5(3):e002919. PubMed ID: 27068631
[TBL] [Abstract][Full Text] [Related]
56. Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.
Gao YM; Li D; Cheng H; Chen YP
Clin Exp Nephrol; 2014 Dec; 18(6):892-8. PubMed ID: 24515307
[TBL] [Abstract][Full Text] [Related]
57. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
[TBL] [Abstract][Full Text] [Related]
58. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
[TBL] [Abstract][Full Text] [Related]
59. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
[TBL] [Abstract][Full Text] [Related]
60. Urinary renalase concentration in patients with preserved kidney function undergoing coronary angiography.
Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
Nephrology (Carlton); 2018 Feb; 23(2):133-138. PubMed ID: 27778420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
